| Gregory Kenneth Suelzle, MD | |
|
1330 San Bernardino Rd, Suite B, Upland, CA 91786-4928 | |
| (909) 981-0608 | |
| (909) 982-5327 |
| Full Name | Gregory Kenneth Suelzle |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 32 Years |
| Location | 1330 San Bernardino Rd, Upland, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326016023 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | G77184 (California) | Primary |
| Entity Name | Gregory K Suelzle Md A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386890044 PECOS PAC ID: 2365598562 Enrollment ID: O20090912000079 |
News Archive
That recommendation comes from a report issued Tuesday by the IMS Institute for Healthcare Informatics, which concluded that those under age 65 have very different health spending habits than Medicare beneficiaries. Meanwhile, experts offer advice to states regarding development of essential benefits packages.
Prostate cancer remains one of the most commonly diagnosed cancers in the United States. In fact, one in six men will develop prostate cancer. It is also the second-leading cause of cancer death in the United States. But a recent survey suggests that many men at risk for the cancer still aren't aware of all available treatment options.
A study of the Grey Bruce Health Network (GBHN) Order Set project has revealed impressive improvements in the length of stay and ordering of best practices.
The research objective of Dr.-Ing. Laura De Laporte, junior group leader at DWI - Leibniz Institute for Interactive Materials in Aachen, is to develop a minimally invasive therapy for spinal cord injury. Her goal and her scientific approach to develop an injectable material with the ability to provide biochemical and physical guidance for regenerating nerves across the injury site, was selected by the European Research Council.
The data, released yesterday, also focuses attention on issues of poverty in the United States, on the role of government programs and on the future of employer-sponsored insurance.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Kenneth Suelzle, MD 1330 San Bernardino Rd, Suite B, Upland, CA 91786-4928 Ph: (909) 981-0608 | Gregory Kenneth Suelzle, MD 1330 San Bernardino Rd, Suite B, Upland, CA 91786-4928 Ph: (909) 981-0608 |
News Archive
That recommendation comes from a report issued Tuesday by the IMS Institute for Healthcare Informatics, which concluded that those under age 65 have very different health spending habits than Medicare beneficiaries. Meanwhile, experts offer advice to states regarding development of essential benefits packages.
Prostate cancer remains one of the most commonly diagnosed cancers in the United States. In fact, one in six men will develop prostate cancer. It is also the second-leading cause of cancer death in the United States. But a recent survey suggests that many men at risk for the cancer still aren't aware of all available treatment options.
A study of the Grey Bruce Health Network (GBHN) Order Set project has revealed impressive improvements in the length of stay and ordering of best practices.
The research objective of Dr.-Ing. Laura De Laporte, junior group leader at DWI - Leibniz Institute for Interactive Materials in Aachen, is to develop a minimally invasive therapy for spinal cord injury. Her goal and her scientific approach to develop an injectable material with the ability to provide biochemical and physical guidance for regenerating nerves across the injury site, was selected by the European Research Council.
The data, released yesterday, also focuses attention on issues of poverty in the United States, on the role of government programs and on the future of employer-sponsored insurance.
› Verified 2 days ago